Johnson & Johnson Seeks US Emergency Approval For Single Dose COVID-19 Vaccine
February 05, 2021 at 05:53 AM EST
Johnson & Johnson said Wednesday that its subsidiary Janssen Biotech Inc is requesting approval from the United States Food and Drug Administration for its single-dose COVID-19 vaccine candidate.
